Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells.

Platelet-derived growth factor (PDGF) and transforming growth factor-beta 1 (TGF-beta 1), two growth-regulatory peptides with opposite effects on arterial smooth muscle cell (ASMC) proliferation, were examined for their influence on the synthesis of two small chondroitin sulfate/dermatan sulfate proteoglycans (CS/DS PGs) called biglycan and decorin. Quiescent ASMCs treated with either PDGF or TGF-beta 1 for 24 hours increased [35S]sulfate incorporation into biglycan 3.3- and 2.9-fold, respectively, whereas the incorporation of [35S]sulfate into decorin was not significantly affected. Treatment with TGF-beta 1 but not PDGF more than doubled the steady-state level of messenger RNA (mRNA) transcripts hybridizing to a complementary DNA (cDNA) encoding biglycan. Both growth factors had little or no effect on steady-state levels of mRNA transcripts hybridizing to a decorin cDNA. Incorporation of [35S]sulfate into biglycan glycosaminoglycan (GAG) was maximal by 12 to 18 hours after either PDGF or TGF-beta 1 addition. Both PDGF and TGF-beta 1 increased the molecular sizes of biglycan and decorin. This increase was a result of the synthesis of longer GAG chains substituted on the core proteins of both PGs. PDGF but not TGF-beta 1 led to an increase of more than twofold in the ratio of 6'- to 4'-sulfated disaccharides in these newly synthesized GAG chains. These results indicate that PDGF and TGF-beta 1 have specific but different effects on the synthesis of small CS/DS PGs by monkey ASMCs in culture.

[1]  Vogel Kg,et al.  The effects of transforming growth factor-beta and serum on proteoglycan synthesis by tendon fibrocartilage. , 1992, European journal of cell biology.

[2]  E. Schönherr,et al.  Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. , 1991, The Journal of biological chemistry.

[3]  S. Schwartz,et al.  Production of transforming growth factor beta 1 during repair of arterial injury. , 1991, The Journal of clinical investigation.

[4]  A. Bassols,et al.  Differential effect of transforming growth factor beta on proteoglycan synthesis in human embryonic lung fibroblasts. , 1991, Biochimica et biophysica acta.

[5]  H. Larjava,et al.  Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. , 1991, The Journal of biological chemistry.

[6]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[7]  C. Wagener,et al.  Purification and N-terminal amino acid sequence of a chondroitin sulphate/dermatan sulphate proteoglycan isolated from intima/media preparations of human aorta. , 1991, The Biochemical journal.

[8]  K. Dreher,et al.  Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall. , 1990, European journal of cell biology.

[9]  M. Young,et al.  Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  S. Schwartz,et al.  PDGF ligand and receptor gene expression during repair of arterial injury , 1990, The Journal of cell biology.

[11]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[12]  L. Peltonen,et al.  Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. , 1990, The Journal of biological chemistry.

[13]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[14]  H. Kresse,et al.  Non-uniform influence of transforming growth factor-beta on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan. , 1990, The Biochemical journal.

[15]  W. Wagner,et al.  Characterization of extracellular matrix proteoglycan transcripts expressed by vascular smooth muscle cells. , 1990, European journal of cell biology.

[16]  A. Gown,et al.  Localization of PDGF-B protein in macrophages in all phases of atherogenesis. , 1990, Science.

[17]  W. Wagner,et al.  Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells. , 1990, The American journal of pathology.

[18]  L. Fransson,et al.  Identification of the core proteins in proteoglycans synthesized by vascular endothelial cells. , 1989, The Biochemical journal.

[19]  M. Young,et al.  Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. , 1989, The Journal of biological chemistry.

[20]  R. Robbins,et al.  Immunolocalization of proteoglycan types in aortas of pigeons with spontaneous or diet-induced atherosclerosis. , 1989, The American journal of pathology.

[21]  L. Tang,et al.  Characterization of the dermatan sulfate proteoglycans, DS-PGI and DS-PGII, from bovine articular cartilage and skin isolated by octyl-sepharose chromatography. , 1989, The Journal of biological chemistry.

[22]  T. Wight,et al.  Isolation and characterization of dermatan sulfate proteoglycans synthesized by cultured bovine aortic endothelial cells. , 1988, The Journal of biological chemistry.

[23]  E. Ruoslahti,et al.  Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation , 1988, Nature.

[24]  T. Wight,et al.  Colloidal gold immunostaining on deplasticized ultra-thin sections. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  Kathleen M. Smith,et al.  Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.

[26]  G. Owens,et al.  Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells , 1988, The Journal of cell biology.

[27]  J. Heino,et al.  Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein. , 1988, The Biochemical journal.

[28]  T. Barrett,et al.  Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Schwartz,et al.  Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Heldin,et al.  Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner , 1988, The Journal of cell biology.

[31]  P. Bornstein,et al.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Termine,et al.  Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone. , 1987, The Biochemical journal.

[33]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[34]  M. Young,et al.  Characterization of bone PG II cDNA and its relationship to PG II mRNA from other connective tissues. , 1986, Nucleic acids research.

[35]  J. Hollmann,et al.  Increased activity of chondroitin sulfate-synthesizing enzymes during proliferation of arterial smooth muscle cells. , 1986, Experimental cell research.

[36]  M. Lark,et al.  Modulation of proteoglycan metabolism by aortic smooth muscle cells grown on collagen gels. , 1986, Arteriosclerosis.

[37]  R. Ross,et al.  Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Ruoslahti,et al.  Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Kresse,et al.  Comparison of small proteoglycans from skin fibroblasts and vascular smooth-muscle cells. , 1986, The Biochemical journal.

[40]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[41]  L. Rosenberg,et al.  Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. , 1986, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  R. Ross.  The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[43]  P. Bornstein,et al.  Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells , 1985, The Journal of cell biology.

[44]  S. Kobayashi,et al.  Highly sulfated proteochondroitin sulfates synthesized in vitro by rat glomeruli. , 1985, Biochimica et biophysica acta.

[45]  L. Tang,et al.  Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. , 1985, The Journal of biological chemistry.

[46]  W. Wagner,et al.  Arterial Dermatan Sulfate Proteoglycan Structure in Pigeons Susceptible to Atherosclerosis , 1985, Arteriosclerosis.

[47]  D. Heinegård,et al.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.

[48]  L. Ehrhart,et al.  Modulation of types I and III procollagen synthesis at various stages of arterial smooth muscle cell growth in vitro. , 1984, Experimental cell research.

[49]  Y. Chang,et al.  Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta. , 1983, The Journal of biological chemistry.

[50]  V. Hascall,et al.  Proteoglycans in primate arteries. III. Characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture , 1983, The Journal of cell biology.

[51]  C. McDevitt,et al.  Effect of purified growth factors on rabbit articular chondrocytes in monolayer culture. II. Sulfated proteoglycan synthesis. , 1982, Arthritis and rheumatism.

[52]  H. Antoniades,et al.  Human platelet-derived growth factor stimulates amino acid transport and protein synthesis by human diploid fibroblasts in plasma-free media. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[53]  E. Canalis.  Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria. , 1981, Metabolism: clinical and experimental.

[54]  W. Wagner,et al.  Aortic Glycosaminoglycans in Genetically Selected WC‐2 Pigeons with Increased Atherosclerosis Susceptibility , 1981, Arteriosclerosis.

[55]  T. Oegema,et al.  Isolation and characterization of proteoglycans from the swarm rat chondrosarcoma. , 1975, The Journal of biological chemistry.

[56]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[57]  T. Yamagata,et al.  Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. , 1968, The Journal of biological chemistry.

[58]  D. M. Carlson.  Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins. , 1968, The Journal of biological chemistry.

[59]  S. Schwartz,et al.  Natural History of Atherosclerosis , 1991 .

[60]  E. Ruoslahti,et al.  Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. , 1990, Kidney international.

[61]  T. Register,et al.  Heterogeneity in glycosylation of dermatan sulfate proteoglycan core proteins isolated from human aorta. , 1990, Connective tissue research.

[62]  T. Wight,et al.  Cell biology of arterial proteoglycans. , 1989, Arteriosclerosis.

[63]  K. Vogel,et al.  Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. , 1989, Matrix.

[64]  Å. Wasteson.  A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate. , 1971, Journal of chromatography.